Lithium Hydroxide → HCID 25065227, compound
Reaction equation
[CH:1]12[CH2:10][CH:5]3[CH2:6][CH:7]([CH2:9][CH:3]([CH2:4]3)[CH:2]1[NH:11][C:12]([N:14]1[CH2:19][CH2:18][C:17]3([C:27]4[C:22](=[CH:23][CH:24]=[C:25]([Cl:28])[CH:26]=4)[CH:21]([CH2:29][C:30]([O:32]CC)=[O:31])[CH2:20]3)[CH2:16][CH2:15]1)=[O:13])[CH2:8]2.[Li+].[OH-]>CO>[CH:1]12[CH2:10][CH:5]3[CH2:6][CH:7]([CH2:9][CH:3]([CH2:4]3)[CH:2]1[NH:11][C:12]([N:14]1[CH2:19][CH2:18][C:17]3([C:27]4[C:22](=[CH:23][CH:24]=[C:25]([Cl:28])[CH:26]=4)[CH:21]([CH2:29][C:30]([OH:32])=[O:31])[CH2:20]3)[CH2:16][CH2:15]1)=[O:13])[CH2:8]2Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (±)-ethyl 2-(1′-((2-adamantyl)carbamoyl)-6-chloro-2,3-dihydrospiro[indene-1,4′-piperidine]-3-yl)acetate (150 mg, 0.3 mmol) in MeOH (3 mL), LiOH (15 mg, 0.6 mmol) was added and the mixture was stirred for 2 h. The solution was concentrated to give the residue, which was purified by preparative HPLC to obtain (±)-2-(1′-((2-adamantyl)carbamoyl)-6-chloro-2,3-dihydrospiro[indene-1,4′-piperidine]-3-yl)acetic acid (10 mg, 7%). LC-MS Method 5 tR=1.485 min, m/z=457.2; 1H NMR (CD3OD): δ=1.59-1.76 (m, 6H), 1.86-1.99 (m, 8H), 1.99-2.19 (m, 6H), 2.48-2.57 (m, 1H), 2.78 (m, 1H), 2.95 (m, 1H), 3.00-3.09 (m, 1H), 3.11-3.23 (m, 1H), 3.69 (m, 1H), 3.94 (s, 1H), 4.06-4.19 (m, 2H), 7.26 (m, 3H).
Workup
- concentrationThe solution was concentrated
- customto give the residue, which
- customwas purified by preparative HPLC
Sources & evidence
- ORD record
- ord-95164c8a56234fa7b306bb5b46c1a3db
- Source dataset
- uspto-grants-2015_01
- Patent number
- US08927715B2
Reaction notes
Loading…